Key result
Etomidate provides superior hemodynamic stability compared to propofol for induction in cardiac surgery, but is associated with adrenal suppression.
Why the study?
Is propofol better than etomidate for induction in cardiac surgical patients?
Is propofol better than etomidate for induction in cardiac surgical patients?
This editorial debates the choice of induction agent in cardiac surgery, highlighting the trade-off between etomidate's hemodynamic stability and its risk of adrenal suppression compared to propofol.
There is an ongoing debate regarding the choice of ideal induction agent between propofol and etomidate for cardiac surgical patients. Etomidate appears to be better than propofol as the induction agent due to the superior hemodynamic stability. However, the adrenal suppression due to etomidate can pose challenges to the anesthesiologist in certain clinical situations.
No takes yet. Share an insight, caveat, or question.
Ladha et al. (2021) studied this question. Etomidate provides superior hemodynamic stability compared to propofol for induction in cardiac surgery, but is associated with adrenal suppression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: